⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for alnuctamab

Every month we try and update this database with for alnuctamab cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study to Evaluate Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)NCT06232707
Multiple Myelom...
Alnuctamab
Pomalidomide
Daratumumab
Elotuzumab
Carfilzomib
Dexamethasone
18 Years - Celgene
A Study to Evaluate Alnuctamab in Combination With Mezigdomide in Participants With Relapsed and/or Refractory Multiple MyelomaNCT06163898
Multiple Myelom...
Alnuctamab
Mezigdomide
Dexamethasone
18 Years - Celgene
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of BMS-986393 in Novel Combinations in Participants With Relapsed and/or Refractory Multiple MyelomaNCT06121843
Multiple Myelom...
BMS-986393
Alnuctamab
Mezigdomide
Iberdomide
18 Years - Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of BMS-986393 in Novel Combinations in Participants With Relapsed and/or Refractory Multiple MyelomaNCT06121843
Multiple Myelom...
BMS-986393
Alnuctamab
Mezigdomide
Iberdomide
18 Years - Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: